LAUREN RUSKELL: Open Payments
NPI 1932576584 · MONTEREY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 16 payments from 9 companies in 2025. Trend: 2023 $733 · 2024 $339 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $105 |
| Smith+Nephew, Inc. | 2 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| Lilly USA, LLC | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| SOBI, INC | 1 | $24 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: COLLAGENASE SANTYL, EPKINLY, VERZENIO, TAGRISSO, ELAHERE, IMBRUVICA, Onivyde, IMFINZI.
Industry payments across CA — which companies pay providers there.
